<DOC>
	<DOCNO>NCT00565630</DOCNO>
	<brief_summary>The purpose study confirm Vigamox reach similar aqueous concentration administer commercially available eye drop spray deliver proprietary device .</brief_summary>
	<brief_title>Using Device Delivering Ophthalmic Solution Spray Form Instead Eye Drops</brief_title>
	<detailed_description>Patients schedule elective cataract surgery , randomly allocate receive Vigamox 4 time , 1 hour prior surgery , either via experimental device spray form , via regular , commercially available bottle . Aqueous sample collect submit masked laboratory measure Vigamox concentration .</detailed_description>
	<mesh_term>Cataract</mesh_term>
	<mesh_term>Norgestimate , ethinyl estradiol drug combination</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Patients schedule elective cataract surgery Known allergy quinolone compound</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2007</verification_date>
</DOC>